植物薬のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Botanical Drug Market Insights and Forecast to 2028

• レポートコード：QY2203B11006 • 出版社/出版日：QYResearch / 2022年3月 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の植物薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に植物薬の世界市場のxxx％を占める「処方薬」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「心臓血管」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の植物薬の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの植物薬市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの植物薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 植物薬のグローバル主要メーカーには、Buchang Pharmaceuticals、China TCM、Tsumura、Schwabe、Tong Ren Tang、Jumpcan Pharmaceutical、Guangzhou Baiyunshan Pharmaceutical、Yunnan Baiyao、Tasly Holding Group、Bionorica Se、Huarun 999、Taiji、Weleda、Kwangdong、GW Pharmaceuticalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 植物薬市場は、種類と用途によって区分されます。世界の植物薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 処方薬、OTC 【用途別セグメント】 心臓血管、腫瘍、呼吸器系、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 植物薬製品概要 - 種類別市場（処方薬、OTC） - 用途別市場（心臓血管、腫瘍、呼吸器系、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の植物薬販売量予測2017-2028 - 世界の植物薬売上予測2017-2028 - 植物薬の地域別販売量 - 植物薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別植物薬販売量 - 主要メーカー別植物薬売上 - 主要メーカー別植物薬価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（処方薬、OTC） - 植物薬の種類別販売量 - 植物薬の種類別売上 - 植物薬の種類別価格 ・用途別市場規模（心臓血管、腫瘍、呼吸器系、その他） - 植物薬の用途別販売量 - 植物薬の用途別売上 - 植物薬の用途別価格 ・北米市場 - 北米の植物薬市場規模（種類別、用途別） - 主要国別の植物薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの植物薬市場規模（種類別、用途別） - 主要国別の植物薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の植物薬市場規模（種類別、用途別） - 主要国別の植物薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の植物薬市場規模（種類別、用途別） - 主要国別の植物薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの植物薬市場規模（種類別、用途別） - 主要国別の植物薬市場規模（トルコ、サウジアラビア） ・企業情報 Buchang Pharmaceuticals、China TCM、Tsumura、Schwabe、Tong Ren Tang、Jumpcan Pharmaceutical、Guangzhou Baiyunshan Pharmaceutical、Yunnan Baiyao、Tasly Holding Group、Bionorica Se、Huarun 999、Taiji、Weleda、Kwangdong、GW Pharmaceuticals ・産業チェーン及び販売チャネル分析 - 植物薬の産業チェーン分析 - 植物薬の原材料 - 植物薬の生産プロセス - 植物薬の販売及びマーケティング - 植物薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 植物薬の産業動向 - 植物薬のマーケットドライバー - 植物薬の課題 - 植物薬の阻害要因 ・主な調査結果

Sales outsourcing is simply this: outsourcing a portion or entire sales activities to a trusted 3rd party sales team. Using a sales outsourcing partner allows companies to attract and maintain a sales force without having to make them full or part-time employees.
Market Analysis and Insights: Global Botanical Drug Market
The global Botanical Drug market size is projected to reach US$ 43150 million by 2028, from US$ 32680 million in 2021, at a CAGR of 4.0% during 2022-2028.
Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, etc. are the leaders of the industry.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 75% in 2019. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of about 16%.
The classification of Botanical Drug includes Prescription Drug and OTC, and the proportion of OTC in 2019 was about 61%.
Botanical Drug is widely used for Cardiovascular, Tumor, Respiratory System, Others. The most proportion of Botanical Drug is Cardiovascular, and the proportion in 2019 was 30%.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Botanical Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Botanical Drug market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Botanical Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Botanical Drug market.
Global Botanical Drug Scope and Market Size
Botanical Drug market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Botanical Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Prescription Drug
OTC
Segment by Application
Cardiovascular
Tumor
Respiratory System
Others
By Company
Buchang Pharmaceuticals
China TCM
Tsumura
Schwabe
Tong Ren Tang
Jumpcan Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Yunnan Baiyao
Tasly Holding Group
Bionorica Se
Huarun 999
Taiji
Weleda
Kwangdong
GW Pharmaceuticals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

---

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Botanical Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Prescription Drug
1.2.3 OTC
1.3 Market by Application
1.3.1 Global Botanical Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cardiovascular
1.3.3 Tumor
1.3.4 Respiratory System
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Botanical Drug Market Perspective (2017-2028)
2.2 Botanical Drug Growth Trends by Region
2.2.1 Botanical Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Botanical Drug Historic Market Size by Region (2017-2022)
2.2.3 Botanical Drug Forecasted Market Size by Region (2023-2028)
2.3 Botanical Drug Market Dynamics
2.3.1 Botanical Drug Industry Trends
2.3.2 Botanical Drug Market Drivers
2.3.3 Botanical Drug Market Challenges
2.3.4 Botanical Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Botanical Drug Players by Revenue
3.1.1 Global Top Botanical Drug Players by Revenue (2017-2022)
3.1.2 Global Botanical Drug Revenue Market Share by Players (2017-2022)
3.2 Global Botanical Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Botanical Drug Revenue
3.4 Global Botanical Drug Market Concentration Ratio
3.4.1 Global Botanical Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Botanical Drug Revenue in 2021
3.5 Botanical Drug Key Players Head office and Area Served
3.6 Key Players Botanical Drug Product Solution and Service
3.7 Date of Enter into Botanical Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Botanical Drug Breakdown Data by Type
4.1 Global Botanical Drug Historic Market Size by Type (2017-2022)
4.2 Global Botanical Drug Forecasted Market Size by Type (2023-2028)
5 Botanical Drug Breakdown Data by Application
5.1 Global Botanical Drug Historic Market Size by Application (2017-2022)
5.2 Global Botanical Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Botanical Drug Market Size (2017-2028)
6.2 North America Botanical Drug Market Size by Type
6.2.1 North America Botanical Drug Market Size by Type (2017-2022)
6.2.2 North America Botanical Drug Market Size by Type (2023-2028)
6.2.3 North America Botanical Drug Market Share by Type (2017-2028)
6.3 North America Botanical Drug Market Size by Application
6.3.1 North America Botanical Drug Market Size by Application (2017-2022)
6.3.2 North America Botanical Drug Market Size by Application (2023-2028)
6.3.3 North America Botanical Drug Market Share by Application (2017-2028)
6.4 North America Botanical Drug Market Size by Country
6.4.1 North America Botanical Drug Market Size by Country (2017-2022)
6.4.2 North America Botanical Drug Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Botanical Drug Market Size (2017-2028)
7.2 Europe Botanical Drug Market Size by Type
7.2.1 Europe Botanical Drug Market Size by Type (2017-2022)
7.2.2 Europe Botanical Drug Market Size by Type (2023-2028)
7.2.3 Europe Botanical Drug Market Share by Type (2017-2028)
7.3 Europe Botanical Drug Market Size by Application
7.3.1 Europe Botanical Drug Market Size by Application (2017-2022)
7.3.2 Europe Botanical Drug Market Size by Application (2023-2028)
7.3.3 Europe Botanical Drug Market Share by Application (2017-2028)
7.4 Europe Botanical Drug Market Size by Country
7.4.1 Europe Botanical Drug Market Size by Country (2017-2022)
7.4.2 Europe Botanical Drug Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Botanical Drug Market Size (2017-2028)
8.2 Asia-Pacific Botanical Drug Market Size by Type
8.2.1 Asia-Pacific Botanical Drug Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Botanical Drug Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Botanical Drug Market Share by Type (2017-2028)
8.3 Asia-Pacific Botanical Drug Market Size by Application
8.3.1 Asia-Pacific Botanical Drug Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Botanical Drug Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Botanical Drug Market Share by Application (2017-2028)
8.4 Asia-Pacific Botanical Drug Market Size by Region
8.4.1 Asia-Pacific Botanical Drug Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Botanical Drug Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Botanical Drug Market Size (2017-2028)
9.2 Latin America Botanical Drug Market Size by Type
9.2.1 Latin America Botanical Drug Market Size by Type (2017-2022)
9.2.2 Latin America Botanical Drug Market Size by Type (2023-2028)
9.2.3 Latin America Botanical Drug Market Share by Type (2017-2028)
9.3 Latin America Botanical Drug Market Size by Application
9.3.1 Latin America Botanical Drug Market Size by Application (2017-2022)
9.3.2 Latin America Botanical Drug Market Size by Application (2023-2028)
9.3.3 Latin America Botanical Drug Market Share by Application (2017-2028)
9.4 Latin America Botanical Drug Market Size by Country
9.4.1 Latin America Botanical Drug Market Size by Country (2017-2022)
9.4.2 Latin America Botanical Drug Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Botanical Drug Market Size (2017-2028)
10.2 Middle East & Africa Botanical Drug Market Size by Type
10.2.1 Middle East & Africa Botanical Drug Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Botanical Drug Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Botanical Drug Market Share by Type (2017-2028)
10.3 Middle East & Africa Botanical Drug Market Size by Application
10.3.1 Middle East & Africa Botanical Drug Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Botanical Drug Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Botanical Drug Market Share by Application (2017-2028)
10.4 Middle East & Africa Botanical Drug Market Size by Country
10.4.1 Middle East & Africa Botanical Drug Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Botanical Drug Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Buchang Pharmaceuticals
11.1.1 Buchang Pharmaceuticals Company Details
11.1.2 Buchang Pharmaceuticals Business Overview
11.1.3 Buchang Pharmaceuticals Botanical Drug Introduction
11.1.4 Buchang Pharmaceuticals Revenue in Botanical Drug Business (2017-2022)
11.1.5 Buchang Pharmaceuticals Recent Developments
11.2 China TCM
11.2.1 China TCM Company Details
11.2.2 China TCM Business Overview
11.2.3 China TCM Botanical Drug Introduction
11.2.4 China TCM Revenue in Botanical Drug Business (2017-2022)
11.2.5 China TCM Recent Developments
11.3 Tsumura
11.3.1 Tsumura Company Details
11.3.2 Tsumura Business Overview
11.3.3 Tsumura Botanical Drug Introduction
11.3.4 Tsumura Revenue in Botanical Drug Business (2017-2022)
11.3.5 Tsumura Recent Developments
11.4 Schwabe
11.4.1 Schwabe Company Details
11.4.2 Schwabe Business Overview
11.4.3 Schwabe Botanical Drug Introduction
11.4.4 Schwabe Revenue in Botanical Drug Business (2017-2022)
11.4.5 Schwabe Recent Developments
11.5 Tong Ren Tang
11.5.1 Tong Ren Tang Company Details
11.5.2 Tong Ren Tang Business Overview
11.5.3 Tong Ren Tang Botanical Drug Introduction
11.5.4 Tong Ren Tang Revenue in Botanical Drug Business (2017-2022)
11.5.5 Tong Ren Tang Recent Developments
11.6 Jumpcan Pharmaceutical
11.6.1 Jumpcan Pharmaceutical Company Details
11.6.2 Jumpcan Pharmaceutical Business Overview
11.6.3 Jumpcan Pharmaceutical Botanical Drug Introduction
11.6.4 Jumpcan Pharmaceutical Revenue in Botanical Drug Business (2017-2022)
11.6.5 Jumpcan Pharmaceutical Recent Developments
11.7 Guangzhou Baiyunshan Pharmaceutical
11.7.1 Guangzhou Baiyunshan Pharmaceutical Company Details
11.7.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
11.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Introduction
11.7.4 Guangzhou Baiyunshan Pharmaceutical Revenue in Botanical Drug Business (2017-2022)
11.7.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments
11.8 Yunnan Baiyao
11.8.1 Yunnan Baiyao Company Details
11.8.2 Yunnan Baiyao Business Overview
11.8.3 Yunnan Baiyao Botanical Drug Introduction
11.8.4 Yunnan Baiyao Revenue in Botanical Drug Business (2017-2022)
11.8.5 Yunnan Baiyao Recent Developments
11.9 Tasly Holding Group
11.9.1 Tasly Holding Group Company Details
11.9.2 Tasly Holding Group Business Overview
11.9.3 Tasly Holding Group Botanical Drug Introduction
11.9.4 Tasly Holding Group Revenue in Botanical Drug Business (2017-2022)
11.9.5 Tasly Holding Group Recent Developments
11.10 Bionorica Se
11.10.1 Bionorica Se Company Details
11.10.2 Bionorica Se Business Overview
11.10.3 Bionorica Se Botanical Drug Introduction
11.10.4 Bionorica Se Revenue in Botanical Drug Business (2017-2022)
11.10.5 Bionorica Se Recent Developments
11.11 Huarun 999
11.11.1 Huarun 999 Company Details
11.11.2 Huarun 999 Business Overview
11.11.3 Huarun 999 Botanical Drug Introduction
11.11.4 Huarun 999 Revenue in Botanical Drug Business (2017-2022)
11.11.5 Huarun 999 Recent Developments
11.12 Taiji
11.12.1 Taiji Company Details
11.12.2 Taiji Business Overview
11.12.3 Taiji Botanical Drug Introduction
11.12.4 Taiji Revenue in Botanical Drug Business (2017-2022)
11.12.5 Taiji Recent Developments
11.13 Weleda
11.13.1 Weleda Company Details
11.13.2 Weleda Business Overview
11.13.3 Weleda Botanical Drug Introduction
11.13.4 Weleda Revenue in Botanical Drug Business (2017-2022)
11.13.5 Weleda Recent Developments
11.14 Kwangdong
11.14.1 Kwangdong Company Details
11.14.2 Kwangdong Business Overview
11.14.3 Kwangdong Botanical Drug Introduction
11.14.4 Kwangdong Revenue in Botanical Drug Business (2017-2022)
11.14.5 Kwangdong Recent Developments
11.15 GW Pharmaceuticals
11.15.1 GW Pharmaceuticals Company Details
11.15.2 GW Pharmaceuticals Business Overview
11.15.3 GW Pharmaceuticals Botanical Drug Introduction
11.15.4 GW Pharmaceuticals Revenue in Botanical Drug Business (2017-2022)
11.15.5 GW Pharmaceuticals Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Botanical Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Prescription Drug
Table 3. Key Players of OTC
Table 4. Global Botanical Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Botanical Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Botanical Drug Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Botanical Drug Market Share by Region (2017-2022)
Table 8. Global Botanical Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Botanical Drug Market Share by Region (2023-2028)
Table 10. Botanical Drug Market Trends
Table 11. Botanical Drug Market Drivers
Table 12. Botanical Drug Market Challenges
Table 13. Botanical Drug Market Restraints
Table 14. Global Botanical Drug Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Botanical Drug Revenue Share by Players (2017-2022)
Table 16. Global Top Botanical Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Botanical Drug as of 2021)
Table 17. Ranking of Global Top Botanical Drug Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Botanical Drug Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Botanical Drug Product Solution and Service
Table 21. Date of Enter into Botanical Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Botanical Drug Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Botanical Drug Revenue Market Share by Type (2017-2022)
Table 25. Global Botanical Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Botanical Drug Revenue Market Share by Type (2023-2028)
Table 27. Global Botanical Drug Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Botanical Drug Revenue Share by Application (2017-2022)
Table 29. Global Botanical Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Botanical Drug Revenue Share by Application (2023-2028)
Table 31. North America Botanical Drug Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Botanical Drug Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Botanical Drug Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Botanical Drug Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Botanical Drug Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Botanical Drug Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Botanical Drug Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Botanical Drug Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Botanical Drug Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Botanical Drug Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Botanical Drug Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Botanical Drug Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Botanical Drug Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Botanical Drug Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Botanical Drug Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Botanical Drug Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Botanical Drug Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Botanical Drug Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Botanical Drug Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Botanical Drug Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Botanical Drug Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Botanical Drug Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Botanical Drug Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Botanical Drug Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Botanical Drug Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Botanical Drug Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Botanical Drug Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Botanical Drug Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Botanical Drug Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Botanical Drug Market Size by Country (2023-2028) & (US$ Million)
Table 61. Buchang Pharmaceuticals Company Details
Table 62. Buchang Pharmaceuticals Business Overview
Table 63. Buchang Pharmaceuticals Botanical Drug Product
Table 64. Buchang Pharmaceuticals Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 65. Buchang Pharmaceuticals Recent Developments
Table 66. China TCM Company Details
Table 67. China TCM Business Overview
Table 68. China TCM Botanical Drug Product
Table 69. China TCM Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 70. China TCM Recent Developments
Table 71. Tsumura Company Details
Table 72. Tsumura Business Overview
Table 73. Tsumura Botanical Drug Product
Table 74. Tsumura Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 75. Tsumura Recent Developments
Table 76. Schwabe Company Details
Table 77. Schwabe Business Overview
Table 78. Schwabe Botanical Drug Product
Table 79. Schwabe Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 80. Schwabe Recent Developments
Table 81. Tong Ren Tang Company Details
Table 82. Tong Ren Tang Business Overview
Table 83. Tong Ren Tang Botanical Drug Product
Table 84. Tong Ren Tang Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 85. Tong Ren Tang Recent Developments
Table 86. Jumpcan Pharmaceutical Company Details
Table 87. Jumpcan Pharmaceutical Business Overview
Table 88. Jumpcan Pharmaceutical Botanical Drug Product
Table 89. Jumpcan Pharmaceutical Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 90. Jumpcan Pharmaceutical Recent Developments
Table 91. Guangzhou Baiyunshan Pharmaceutical Company Details
Table 92. Guangzhou Baiyunshan Pharmaceutical Business Overview
Table 93. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product
Table 94. Guangzhou Baiyunshan Pharmaceutical Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 95. Guangzhou Baiyunshan Pharmaceutical Recent Developments
Table 96. Yunnan Baiyao Company Details
Table 97. Yunnan Baiyao Business Overview
Table 98. Yunnan Baiyao Botanical Drug Product
Table 99. Yunnan Baiyao Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 100. Yunnan Baiyao Recent Developments
Table 101. Tasly Holding Group Company Details
Table 102. Tasly Holding Group Business Overview
Table 103. Tasly Holding Group Botanical Drug Product
Table 104. Tasly Holding Group Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 105. Tasly Holding Group Recent Developments
Table 106. Bionorica Se Company Details
Table 107. Bionorica Se Business Overview
Table 108. Bionorica Se Botanical Drug Product
Table 109. Bionorica Se Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 110. Bionorica Se Recent Developments
Table 111. Huarun 999 Company Details
Table 112. Huarun 999 Business Overview
Table 113. Huarun 999 Botanical Drug Product
Table 114. Huarun 999 Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 115. Huarun 999 Recent Developments
Table 116. Taiji Company Details
Table 117. Taiji Business Overview
Table 118. Taiji Botanical Drug Product
Table 119. Taiji Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 120. Taiji Recent Developments
Table 121. Weleda Company Details
Table 122. Weleda Business Overview
Table 123. Weleda Botanical Drug Product
Table 124. Weleda Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 125. Weleda Recent Developments
Table 126. Kwangdong Company Details
Table 127. Kwangdong Business Overview
Table 128. Kwangdong Botanical Drug Product
Table 129. Kwangdong Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 130. Kwangdong Recent Developments
Table 131. GW Pharmaceuticals Company Details
Table 132. GW Pharmaceuticals Business Overview
Table 133. GW Pharmaceuticals Botanical Drug Product
Table 134. GW Pharmaceuticals Revenue in Botanical Drug Business (2017-2022) & (US$ Million)
Table 135. GW Pharmaceuticals Recent Developments
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Botanical Drug Market Share by Type: 2021 VS 2028
Figure 2. Prescription Drug Features
Figure 3. OTC Features
Figure 4. Global Botanical Drug Market Share by Application: 2021 VS 2028
Figure 5. Cardiovascular Case Studies
Figure 6. Tumor Case Studies
Figure 7. Respiratory System Case Studies
Figure 8. Others Case Studies
Figure 9. Botanical Drug Report Years Considered
Figure 10. Global Botanical Drug Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Botanical Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Botanical Drug Market Share by Region: 2021 VS 2028
Figure 13. Global Botanical Drug Market Share by Players in 2021
Figure 14. Global Top Botanical Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Botanical Drug as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Botanical Drug Revenue in 2021
Figure 16. North America Botanical Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Botanical Drug Market Size Market Share by Type (2017-2028)
Figure 18. North America Botanical Drug Market Size Market Share by Application (2017-2028)
Figure 19. North America Botanical Drug Market Size Share by Country (2017-2028)
Figure 20. United States Botanical Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Botanical Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Botanical Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Botanical Drug Market Size Market Share by Type (2017-2028)
Figure 24. Europe Botanical Drug Market Size Market Share by Application (2017-2028)
Figure 25. Europe Botanical Drug Market Size Share by Country (2017-2028)
Figure 26. Germany Botanical Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Botanical Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Botanical Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Botanical Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Botanical Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Botanical Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Botanical Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Botanical Drug Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Botanical Drug Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Botanical Drug Market Size Share by Region (2017-2028)
Figure 36. China Botanical Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Botanical Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Botanical Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Botanical Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Botanical Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Botanical Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Latin America Botanical Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Botanical Drug Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Botanical Drug Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Botanical Drug Market Size Share by Country (2017-2028)
Figure 46. Mexico Botanical Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Botanical Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Botanical Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Botanical Drug Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Botanical Drug Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Botanical Drug Market Size Share by Country (2017-2028)
Figure 52. Turkey Botanical Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Botanical Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Botanical Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Buchang Pharmaceuticals Revenue Growth Rate in Botanical Drug Business (2017-2022)
Figure 56. China TCM Revenue Growth Rate in Botanical Drug Business (2017-2022)
Figure 57. Tsumura Revenue Growth Rate in Botanical Drug Business (2017-2022)
Figure 58. Schwabe Revenue Growth Rate in Botanical Drug Business (2017-2022)
Figure 59. Tong Ren Tang Revenue Growth Rate in Botanical Drug Business (2017-2022)
Figure 60. Jumpcan Pharmaceutical Revenue Growth Rate in Botanical Drug Business (2017-2022)
Figure 61. Guangzhou Baiyunshan Pharmaceutical Revenue Growth Rate in Botanical Drug Business (2017-2022)
Figure 62. Yunnan Baiyao Revenue Growth Rate in Botanical Drug Business (2017-2022)
Figure 63. Tasly Holding Group Revenue Growth Rate in Botanical Drug Business (2017-2022)
Figure 64. Bionorica Se Revenue Growth Rate in Botanical Drug Business (2017-2022)
Figure 65. Huarun 999 Revenue Growth Rate in Botanical Drug Business (2017-2022)
Figure 66. Taiji Revenue Growth Rate in Botanical Drug Business (2017-2022)
Figure 67. Weleda Revenue Growth Rate in Botanical Drug Business (2017-2022)
Figure 68. Kwangdong Revenue Growth Rate in Botanical Drug Business (2017-2022)
Figure 69. GW Pharmaceuticals Revenue Growth Rate in Botanical Drug Business (2017-2022)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---